+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Oxidative Stress Assay Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments, and Services), By Test Type, By Technology, By Disease Type, By End-user, By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • 137 Pages
  • March 2024
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5953468
The North America Oxidative Stress Assay Market would witness market growth of 8.6% CAGR during the forecast period (2023-2030).

The US market dominated the North America Oxidative Stress Assay Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $497 million by 2030. The Canada market is experiencing a CAGR of 11.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 10.1% during (2023 - 2030).



The utilization of this is of the utmost importance when examining the involvement of oxidative stress in developing a wide range of diseases. These diseases include cardiovascular disorders, cancer, diabetes, and neurodegenerative disorders (e.g., Alzheimer's and Parkinson's).

Moreover, it helps assess the antioxidant capacity of foods and nutritional supplements, providing valuable information about their potential health benefits. Researchers use this to investigate how dietary components influence oxidative stress levels and overall cellular health.

According to the Canadian Institute for Health Information, Canada's senior population of those 65 and older will expand by 68% over the next 20 years. It has more than tripled in size in the last 40 years. In 2017, it was around 6.2 million. It is anticipated to reach 10.4 million in 2037. This population in Canada is projected to increase by 2.1 times by 2037 from its size in 2017.

Based on Product, the market is segmented into Consumables, Instruments, and Services. Based on Test Type, the market is segmented into Indirect Assays, Antioxidant Capacity Assays, Enzyme-Based Assays, and Reactive Oxygen Species-Based Assays. Based on Technology, the market is segmented into Enzyme-linked Immunosorbent Assay (ELISA), Flow Cytometry, Chromatography, Microscopy, and Others. Based on Disease Type, the market is segmented into Cardiovascular Disease, Respiratory Diseases, Cancer, Diabetes, and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Industries, Contract Research Organizations, Academic Research Institutes, Clinical Laboratories, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

  • Abcam Plc (Danaher Corporation)
  • Merck KGaA
  • Promega Corporation
  • Qiagen N.V
  • Thermo Fisher Scientific, Inc.
  • Cayman Chemical Company, Inc.
  • AMS Biotechnology (Europe) Limited.
  • Cell Biolabs, Inc.
  • Enzo Life Sciences, Inc. (Enzo Biochem, Inc.)
  • ImmunoChemistry Technologies

Market Report Segmentation

By Product
  • Consumables
  • Instruments
  • Services
By Test Type
  • Indirect Assays
  • Antioxidant Capacity Assays
  • Enzyme-Based Assays
  • Reactive Oxygen Species-Based Assays
By Technology
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Flow Cytometry
  • Chromatography
  • Microscopy
  • Others
By Disease Type
  • Cardiovascular Disease
  • Respiratory Diseases
  • Cancer
  • Diabetes
  • Others
By End-user
  • Pharmaceutical & Biotechnology Industries
  • Contract Research Organizations
  • Academic Research Institutes
  • Clinical Laboratories
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Oxidative Stress Assay Market, by Product
1.4.2 North America Oxidative Stress Assay Market, by Test Type
1.4.3 North America Oxidative Stress Assay Market, by Technology
1.4.4 North America Oxidative Stress Assay Market, by Disease Type
1.4.5 North America Oxidative Stress Assay Market, by End-user
1.4.6 North America Oxidative Stress Assay Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Oxidative Stress Assay Market by Product
4.1 North America Consumables Market by Country
4.2 North America Instruments Market by Country
4.3 North America Services Market by Country
Chapter 5. North America Oxidative Stress Assay Market by Test Type
5.1 North America Indirect Assays Market by Country
5.2 North America Antioxidant Capacity Assays Market by Country
5.3 North America Enzyme-Based Assays Market by Country
5.4 North America Reactive Oxygen Species-Based Assays Market by Country
Chapter 6. North America Oxidative Stress Assay Market by Technology
6.1 North America Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
6.2 North America Flow Cytometry Market by Country
6.3 North America Chromatography Market by Country
6.4 North America Microscopy Market by Country
6.5 North America Others Market by Country
Chapter 7. North America Oxidative Stress Assay Market by Disease Type
7.1 North America Cardiovascular Disease Market by Country
7.2 North America Respiratory Diseases Market by Country
7.3 North America Cancer Market by Country
7.4 North America Diabetes Market by Country
7.5 North America Others Market by Country
Chapter 8. North America Oxidative Stress Assay Market by End-user
8.1 North America Pharmaceutical & Biotechnology Industries Market by Country
8.2 North America Contract Research Organizations Market by Country
8.3 North America Academic Research Institutes Market by Country
8.4 North America Clinical Laboratories Market by Country
8.5 North America Others Market by Country
Chapter 9. North America Oxidative Stress Assay Market by Country
9.1 US Oxidative Stress Assay Market
9.1.1 US Oxidative Stress Assay Market by Product
9.1.2 US Oxidative Stress Assay Market by Test Type
9.1.3 US Oxidative Stress Assay Market by Technology
9.1.4 US Oxidative Stress Assay Market by Disease Type
9.1.5 US Oxidative Stress Assay Market by End-user
9.2 Canada Oxidative Stress Assay Market
9.2.1 Canada Oxidative Stress Assay Market by Product
9.2.2 Canada Oxidative Stress Assay Market by Test Type
9.2.3 Canada Oxidative Stress Assay Market by Technology
9.2.4 Canada Oxidative Stress Assay Market by Disease Type
9.2.5 Canada Oxidative Stress Assay Market by End-user
9.3 Mexico Oxidative Stress Assay Market
9.3.1 Mexico Oxidative Stress Assay Market by Product
9.3.2 Mexico Oxidative Stress Assay Market by Test Type
9.3.3 Mexico Oxidative Stress Assay Market by Technology
9.3.4 Mexico Oxidative Stress Assay Market by Disease Type
9.3.5 Mexico Oxidative Stress Assay Market by End-user
9.4 Rest of North America Oxidative Stress Assay Market
9.4.1 Rest of North America Oxidative Stress Assay Market by Product
9.4.2 Rest of North America Oxidative Stress Assay Market by Test Type
9.4.3 Rest of North America Oxidative Stress Assay Market by Technology
9.4.4 Rest of North America Oxidative Stress Assay Market by Disease Type
9.4.5 Rest of North America Oxidative Stress Assay Market by End-user
Chapter 10. Company Profiles
10.1 Abcam Plc (Danaher Corporation)
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 SWOT Analysis
10.2 Merck KGaA
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 SWOT Analysis
10.3 Promega Corporation
10.3.1 Company Overview
10.3.2 SWOT Analysis
10.4 Qiagen N.V.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 SWOT Analysis
10.5 Thermo Fisher Scientific, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Cayman Chemical Company, Inc.
10.6.1 Company Overview
10.6.2 SWOT Analysis
10.7 AMS Biotechnology (Europe) Limited.
10.7.1 Company Overview
10.7.2 SWOT Analysis
10.8 Cell Biolabs, Inc.
10.8.1 Company Overview
10.8.2 SWOT Analysis
10.9 Enzo Life Sciences, Inc. (Enzo Biochem, Inc.)
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expenses
10.9.5 SWOT Analysis
10.10. ImmunoChemistry Technologies
10.10.1 Company Overview
10.10.2 SWOT Analysis

Companies Mentioned

  • Abcam Plc (Danaher Corporation)
  • Merck KGaA
  • Promega Corporation
  • Qiagen N.V
  • Thermo Fisher Scientific, Inc.
  • Cayman Chemical Company, Inc.
  • AMS Biotechnology (Europe) Limited.
  • Cell Biolabs, Inc.
  • Enzo Life Sciences, Inc. (Enzo Biochem, Inc.)
  • ImmunoChemistry Technologies

Methodology

Loading
LOADING...